1. Home
  2. ELUT

as of 12-30-2025 3:55pm EST

$0.59
+$0.04
+7.85%
Stocks Health Care Medical Specialities Nasdaq

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

Founded: 2015 Country:
United States
United States
Employees: N/A City: SILVER SPRING
Market Cap: 23.3M IPO Year: 2020
Target Price: $7.00 AVG Volume (30 days): 502.1K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.99 EPS Growth: N/A
52 Week Low/High: $0.50 - $3.99 Next Earning Date: 11-06-2025
Revenue: $21,746,000 Revenue Growth: 24.08%
Revenue Growth (this year): -21.75% Revenue Growth (next year): -18.18%

AI-Powered ELUT Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 74.19%
74.19%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of Elutia Inc. (ELUT)

Buy
ELUT Dec 17, 2025

Avg Cost/Share

$0.52

Shares

25,000

Total Value

$13,000.00

Owned After

27,000

SEC Form 4

Ferguson Matthew

CHIEF FINANCIAL OFFICER

Buy
ELUT Dec 17, 2025

Avg Cost/Share

$0.53

Shares

60,000

Total Value

$31,800.00

Owned After

447,110

SEC Form 4

Mills C Randal

PRESIDENT AND CEO

Buy
ELUT Dec 17, 2025

Avg Cost/Share

$0.51

Shares

3,000

Total Value

$1,530.00

Owned After

379,204

SEC Form 4

RAKIN KEVIN

Director, 10% Owner

Buy
ELUT Dec 17, 2025

Avg Cost/Share

$0.52

Shares

50,000

Total Value

$25,995.00

Owned After

322,419

SEC Form 4

Buy
ELUT Dec 17, 2025

Avg Cost/Share

$0.51

Shares

12,500

Total Value

$6,375.00

Owned After

31,098

SEC Form 4

Ferguson Matthew

CHIEF FINANCIAL OFFICER

Buy
ELUT Dec 2, 2025

Avg Cost/Share

$0.67

Shares

5,500

Total Value

$3,685.00

Owned After

447,110

SEC Form 4

Ferguson Matthew

CHIEF FINANCIAL OFFICER

Buy
ELUT Dec 1, 2025

Avg Cost/Share

$0.65

Shares

4,500

Total Value

$2,925.00

Owned After

447,110

SEC Form 4

Mills C Randal

PRESIDENT AND CEO

Buy
ELUT Nov 24, 2025

Avg Cost/Share

$0.60

Shares

5,000

Total Value

$3,000.00

Owned After

379,204

SEC Form 4

Buy
ELUT Nov 17, 2025

Avg Cost/Share

$0.74

Shares

15,500

Total Value

$11,470.00

Owned After

31,098

SEC Form 4

Mills C Randal

PRESIDENT AND CEO

Buy
ELUT Nov 13, 2025

Avg Cost/Share

$0.75

Shares

13,500

Total Value

$10,110.00

Owned After

379,204

SEC Form 4

Form 1 Form 2

Latest Elutia Inc. News

ELUT Breaking Stock News: Dive into ELUT Ticker-Specific Updates for Smart Investing

All ELUT News

Share on Social Networks: